What are the possible differential diagnoses for a patient presenting with sudden onset of pruritic, erythematous, migratory rashes, and what are their diagnostic criteria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnoses for Acute Urticaria with Target-Like Lesions in a Toddler

Critical Clinical Assessment

The presence of target-like lesions with persistent, non-raised, blanchable macular components lasting >24 hours mandates immediate consideration of erythema multiforme (EM) rather than simple acute urticaria, and requires urgent skin biopsy to exclude urticarial vasculitis. 1, 2


Table: Differential Diagnoses That Cannot Be Ruled Out

Differential Diagnosis Key Diagnostic Features Patient's Manifestations Why Cannot Be Ruled Out Yet What's Missing/Needed
Erythema Multiforme Minor • Target-like lesions (pathognomonic)
• Fixed lesions persisting >24 hours
• Symmetrical distribution on extremities, face
• May have central vesiculation
• Preceded by HSV or Mycoplasma infection [2]
• (+) Target-like lesions on scalp, face, back, abdomen, groin, arms, legs
• (+) Persistent rashes for >24 hours
• (+) Fever
• (+) Symmetrical distribution
• Target morphology is pathognomonic for EM, not urticaria [2]
• Lesions persisting >24 hours favor EM over urticaria (which resolves within 24 hours) [1,2]
• Previous episode suggests recurrent EM pattern
Skin biopsy showing interface dermatitis with keratinocyte necrosis and lymphocytic infiltrate [2]
• HSV serology or PCR
• Mycoplasma serology
• Document if individual lesions are truly fixed vs. migratory
Urticarial Vasculitis • Individual lesions lasting >24 hours
• Burning/pain rather than pure pruritus
• Residual purpura, ecchymosis, or hyperpigmentation after resolution
• Elevated ESR/CRP
• Low complement (C3, C4) [1]
• (+) Lesions present for >24 hours
• (+) Pruritic (but need to assess for burning/pain)
• (+) Mild leukocytosis (14.39 × 10⁹/L)
• (+) Some lesions have random shapes
• Lesion duration >24 hours strongly suggests vasculitis [1]
• Mild leukocytosis may indicate inflammatory/vasculitic process [1]
• Target-like appearance can occur in vasculitis
Lesional skin biopsy showing leukocytoclastic vasculitis with fibrinoid necrosis [1]
• ESR and CRP levels [1]
• Complement levels (C3, C4) [1]
• Document if lesions leave purpura or hyperpigmentation [1]
Urticaria Multiforme • Annular, polycyclic urticarial plaques with dusky, ecchymotic centers
• Acral edema (hands, feet, face)
• Pruritic
• Individual lesions resolve within 24 hours
• Benign, self-limited (typically viral trigger) [3,4]
• (+) Target-like lesions (could be polycyclic plaques)
• (+) Pruritic
• (+) Face and scalp involvement
• (+) Fever
• (+) Recent urticaria episode
• Polycyclic urticarial plaques can mimic target lesions [3,4]
• Fever and viral prodrome common [3]
• Age-appropriate (common in toddlers) [3]
Document lesion duration (should resolve within 24 hours) [3]
• Assess for acral edema [3]
• Skin biopsy shows dermal edema and perivascular infiltrate WITHOUT keratinocyte damage [2,3]
Acute Hemorrhagic Edema of Infancy (AHEI) • Age 4-24 months (peak incidence)
• Large targetoid purpuric plaques on face and extremities
• Marked acral edema
• Fever
• Benign, self-limited
• Normal platelet count [3]
• (+) Age 23 months (within range)
• (+) Face and extremity involvement
• (+) Fever
• (+) Normal platelet count (275 × 10⁹/L)
• (?) Need to assess for purpura vs. blanching
• Age-appropriate for AHEI [3]
• Distribution matches (face, extremities) [3]
• Fever present [3]
• Need to clarify if lesions are truly purpuric or blanchable
Clarify if lesions are purpuric (non-blanching) or erythematous (blanching) [3]
• Assess for marked acral edema [3]
• Skin biopsy shows leukocytoclastic vasculitis in small vessels [3]
Viral Exanthem with Urticarial Features • Acute onset with fever
• Maculopapular or urticarial rash
• Systemic symptoms (malaise, fever)
• Self-limited
• May have atypical morphology [2,3]
• (+) Fever
• (+) Acute onset
• (+) Erythematous macular rash
• (+) Pruritic
• (+) Mild leukocytosis
• Viral infections commonly cause urticarial or maculopapular rashes in toddlers [3]
• Fever and leukocytosis support viral etiology
• Target-like appearance can occur in viral exanthems [2]
Viral serologies (EBV, CMV, enterovirus, adenovirus)
• Skin biopsy shows variable non-specific perivascular lymphocytic infiltrate [2]
• Clinical observation for evolution and resolution pattern
Serum Sickness-Like Reaction (SSLR) • Urticarial rash with purpuric or targetoid features
• Fever, arthralgia, lymphadenopathy
• Occurs 7-14 days after medication/infection exposure
• Elevated ESR [3]
• (+) Urticarial rash with target-like features
• (+) Fever
• (+) Recent medication exposure (cetirizine, paracetamol)
• (?) Need to assess for arthralgia, lymphadenopathy
• Target-like lesions can occur in SSLR [3]
• Fever present [3]
• Recent medication exposure (though timing unclear) [3]
Detailed medication timeline (7-14 days before onset) [3]
• Assess for arthralgia and lymphadenopathy [3]
• ESR level [3]
• Skin biopsy shows perivascular lymphocytic infiltrate [3]

Algorithmic Approach to Differentiation

Step 1: Document Individual Lesion Duration

  • If lesions resolve within 24 hours: Favors acute urticaria or urticaria multiforme 1, 2, 3
  • If lesions persist >24 hours: Strongly suggests erythema multiforme or urticarial vasculitis 1, 2

Step 2: Assess Lesion Characteristics After Resolution

  • No residual marks: Favors urticaria or urticaria multiforme 1, 2
  • Purpura, ecchymosis, or hyperpigmentation: Pathognomonic for urticarial vasculitis 1

Step 3: Evaluate Symptom Quality

  • Pure pruritus: Favors urticaria, urticaria multiforme, or viral exanthem 1, 3
  • Burning or pain: Suggests urticarial vasculitis 1

Step 4: Assess for Acral Edema

  • Marked acral edema (hands, feet, face): Suggests urticaria multiforme or AHEI 3
  • No significant edema: Favors EM, viral exanthem, or SSLR 2, 3

Step 5: Determine if Lesions Are Blanching

  • Completely blanching: Favors urticaria, urticaria multiforme, EM, or viral exanthem 2, 3
  • Non-blanching (purpuric): Suggests AHEI or urticarial vasculitis 1, 3

Mandatory Investigations

Immediate (Within 24-48 Hours)

  • Lesional skin biopsy (mandatory given target-like lesions and persistence >24 hours) 1, 2
    • Interface dermatitis with keratinocyte necrosis → EM 2
    • Leukocytoclastic vasculitis → Urticarial vasculitis or AHEI 1, 3
    • Dermal edema without keratinocyte damage → Urticaria or urticaria multiforme 2, 3

Laboratory Workup

  • ESR and CRP (to evaluate for vasculitis or autoinflammatory disease) 1, 3
  • Complement levels (C3, C4) (if urticarial vasculitis suspected) 1
  • Viral serologies (EBV, CMV, enterovirus, adenovirus) 2, 3
  • HSV serology or PCR (EM commonly triggered by HSV) 2
  • Mycoplasma serology (EM trigger in children) 2

Clinical Documentation

  • Mark lesion borders with ink and photograph to assess migration vs. fixed nature 5
  • Document exact duration of individual lesions (set timer for 24 hours) 1, 2
  • Assess for acral edema (hands, feet, face) 3
  • Detailed medication timeline (7-14 days before onset for SSLR) 3

Critical Pitfalls to Avoid

Pitfall 1: Assuming All Pruritic Rashes Are Urticaria

  • Target-like lesions are NOT characteristic of ordinary urticaria and mandate consideration of EM or vasculitis 1, 2
  • Do not dismiss target morphology as "atypical urticaria" without biopsy 1, 2

Pitfall 2: Delaying Skin Biopsy

  • Lesions persisting >24 hours with target morphology require immediate biopsy to differentiate EM from urticarial vasculitis 1, 2
  • Biopsy is the only definitive way to distinguish these entities 1, 2

Pitfall 3: Over-Relying on Antihistamine Response

  • Lack of response to cetirizine does NOT rule out urticaria but increases suspicion for EM or vasculitis 1, 2
  • EM and vasculitis do not respond to antihistamines 2, 3

Pitfall 4: Missing AHEI in This Age Group

  • AHEI is age-appropriate (4-24 months) and presents with targetoid purpuric plaques that can mimic EM 3
  • Key differentiator is purpura (non-blanching) vs. erythema (blanching) 3

Pitfall 5: Ignoring Recurrence Pattern

  • Previous episode of "acute urticaria" may have been misdiagnosed EM 2
  • Recurrent EM is common and often HSV-triggered 2

Management Pending Definitive Diagnosis

Supportive Care

  • Continue antihistamines (cetirizine) for symptomatic relief, though response is limited in EM or vasculitis 2, 3
  • Topical corticosteroids for pruritus 5
  • Avoid NSAIDs until urticarial vasculitis is excluded (may worsen vasculitis) 1

Monitoring

  • Daily assessment for development of mucosal involvement (would upgrade to EM major) 2
  • Monitor for systemic symptoms (arthralgia, abdominal pain, renal involvement) suggesting vasculitis or systemic disease 1, 3
  • Photograph lesions daily to document evolution 5, 2

When to Escalate

  • Mucosal involvement (oral, ocular, genital) → EM major or Stevens-Johnson syndrome 2
  • Respiratory distress or angioedema → Anaphylaxis (though unlikely given presentation) 5, 6
  • Systemic symptoms (arthralgia, abdominal pain, hematuria) → Urticarial vasculitis or systemic disease 1, 3

References

Guideline

Differential Diagnoses for Acute Urticaria with Target-Like Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Erythema Multiforme Minor Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Urticaria mimickers in children.

Dermatologic therapy, 2013

Research

Annular urticarial lesions.

Clinics in dermatology, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.